Long Covid – The illness narratives.
Long Covid – The illness narratives – Social Science & Medicine Commentary on Twitter Our qualitative study of Long Covid was the largest sample (114) published to date. We showed, beyond any reasonable doubt, that this illness is NOT limited to 12 predefined tick-box symptoms. Its key characteristic is 'strangeness' and fluctuation. https://t.co/j6z1u0IYOu pic.twitter.com/C8Hyy9DSms […]
The post Long Covid – The illness narratives. appeared first on Links Medicus.
Six rules that will define our second pandemic winter
Six Rules That Will Define Our Second Pandemic Winter – The Atlantic
The post Six rules that will define our second pandemic winter appeared first on Links Medicus.
COVID will likely shift from pandemic to endemic — but what does that mean?
COVID will likely shift from pandemic to endemic — but what does that mean? – The Conversation
The post COVID will likely shift from pandemic to endemic — but what does that mean? appeared first on Links Medicus.
An Update on Coronavirus Disease 2019 (COVID-19) and Pregnancy.
An Update on Coronavirus Disease 2019 (COVID-19) and Pregnancy – American Journal of Obstetrics and Gynecology
The post An Update on Coronavirus Disease 2019 (COVID-19) and Pregnancy. appeared first on Links Medicus.
M-A: Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19 – According to this analysis, standard-dose prophylactic anticoagulation should be the standard of care for hosp
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials – European Heart Journal – Cardiovascular Pharmacotherapy Commentary on Twitter (thread – click for more) Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically […]
The post M-A: Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19 – According to this analysis, standard-dose prophylactic anticoagulation should be the standard of care for hospitalized patients with COVID-19 who do not have an indication for therapeutic anticoagulation, irrespective of disease severity. appeared first on Links Medicus.
Review: Transfusion-related acute lung injury in the perioperative patient.
Transfusion-related Acute Lung Injury in the Perioperative Patient – Anesthesiology
The post Review: Transfusion-related acute lung injury in the perioperative patient. appeared first on Links Medicus.
COVID vaccine immunity is waning — how much does that matter? – “As debates about booster shots heat up, what’s known about the duration of vaccine-based immunity is still evolving”.
COVID vaccine immunity is waning — how much does that matter? – Nature
The post COVID vaccine immunity is waning — how much does that matter? – “As debates about booster shots heat up, what’s known about the duration of vaccine-based immunity is still evolving”. appeared first on Links Medicus.
Does everybody need a booster shot? – “Why some people might need Covid-19 booster shots — and some might not”.
Does everybody need a booster shot? – Vox
The post Does everybody need a booster shot? – “Why some people might need Covid-19 booster shots — and some might not”. appeared first on Links Medicus.
An FDA panel says only high-risk Americans and those 65+ should get covid boosters.
An FDA Panel Says Only High-Risk Americans And Those 65+ Should Get COVID Boosters – NPR See also: FDA advisory panel recommends booster doses of Covid-19 vaccine only for older and high-risk Americans – STAT 5 reasons why FDA advisers did not recommend Covid-19 booster shots for everyone – CNN Top doctors say not so […]
The post An FDA panel says only high-risk Americans and those 65+ should get covid boosters. appeared first on Links Medicus.
CDC Report: Moderna’s vaccine associated with greater effectiveness (93%) against Covid-19 hospitalization compared to Pfizer (88%) and J&J (71%) vaccines.
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 – CDC Morbidity and Mortality Weekly Report Commentaries: Moderna’s vaccine is the most effective, but Pfizer and J&J also protect well, CDC-led study says – CNN CDC: Moderna COVID vaccine […]
The post CDC Report: Moderna’s vaccine associated with greater effectiveness (93%) against Covid-19 hospitalization compared to Pfizer (88%) and J&J (71%) vaccines. appeared first on Links Medicus.